Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1959 Sep 30;110(4):617–628. doi: 10.1084/jem.110.4.617

STUDIES ON THE PATHOGENICITY OF GROUP A STREPTOCOCCI

II. THE ANTIPHAGOCYTIC EFFECTS OF THE M PROTEIN AND THE CAPSULAR GEL

Marie Judith Foley 1, W Barry Wood Jr 1
PMCID: PMC2137000  PMID: 13823728

Abstract

A quantitative study of the combined antiphagocytic effects of the M protein and the hyaluronic acid capsules of four strains of Group A streptococci revealed the following facts relating to their intraperitoneal virulence in mice and rats: 1. The most virulent strain, S23M (matt), produced both a large hyaluronic acid capsule and a full complement of M protein, the combined effects of which rendered the organism highly resistant to surface phagocytosis. 2. The slightly less virulent strain, T14/46 (matt virulent) was somewhat more susceptible to surface phagocytosis owing to the fact that its smaller capsule was less antiphagocytic than that of the S23M organism. 3. The glossy variant of the S23 strain (S23G), which ranked third in virulence, was still more susceptible to surface phagocytosis because of its lack of detectable M substance. Its large hyaluronic acid capsule, however, was capable of protecting it against phagocytosis on glass. 4. The least virulent strain, T14 (matt avirulent), was the most susceptible of all to phagocytosis. Though it possessed both M substance and capsule, which together prevented its phagocytosis on glass, each of them was shown to be quantitatively and functionally deficient as compared to Strain S23M. The differences in phagocytability, which appear to be directly related to the pathogenicity of the organisms, could be adequately demonstrated in vitro only by phagocytic tests designed to measure surface phagocytosis in the absence of opsonins. This fact is in keeping with the observation, previously reported, that surface phagocytosis plays a critical role in the defense of the host, particularly during the earliest stages of experimental streptococcal infections. Its possible relation to suppuration during the later stages of infection is also discussed.

Full Text

The Full Text of this article is available as a PDF (797.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. FOLEY M. J., SMITH M. R., WOOD W. B., Jr Studies on the pathogenicity of group A Streptococci. I. Its relation to surface phagocytosis. J Exp Med. 1959 Oct 1;110:603–616. doi: 10.1084/jem.110.4.603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. GLASER R. J., BERRY J. W., LOEB L. H. Production of group A streptococcal cervical lymphadenitis in mice. Proc Soc Exp Biol Med. 1953 Jan;82(1):87–92. doi: 10.3181/00379727-82-20032. [DOI] [PubMed] [Google Scholar]
  3. GLASER R. J., WOOD W. B., Jr Pathogenesis of streptococcal pneumonia in the rat. AMA Arch Pathol. 1951 Sep;52(3):244–252. [PubMed] [Google Scholar]
  4. KRASNER R. I., YOUNG G. Role of hyaluronidase and the hyaluronic acid capsule in the survival and dissemination of group A streptococci in the hamster cheek pouch. J Bacteriol. 1958 Oct;76(4):349–354. doi: 10.1128/jb.76.4.349-354.1958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kass E. H., Seastone C. V. THE ROLE OF THE MUCOID POLYSACCHARIDE (HYALURONIC ACID) IN THE VIRULENCE OF GROUP A HEMOLYTIC STREPTOCOCCI. J Exp Med. 1944 Mar 1;79(3):319–330. doi: 10.1084/jem.79.3.319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. LUDANY G., ORBAN T., VAJDA J. Hyaluronidase und die Bakterienphagozytose der Leukozyten. Arch Int Pharmacodyn Ther. 1952 Jan;88(4):496–502. [PubMed] [Google Scholar]
  7. Lancefield R. C. STUDIES ON THE ANTIGENIC COMPOSITION OF GROUP A HEMOLYTIC STREPTOCOCCI : I. EFFECTS OF PROTEOLYTIC ENZYMES ON STREPTOCOCCAL CELLS. J Exp Med. 1943 Dec 1;78(6):465–476. doi: 10.1084/jem.78.6.465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. MORRIS M., SEASTONE C. V. The relationship of M protein and resistance to phagocytosis in the beta hemolytic streptococci. J Bacteriol. 1955 Feb;69(2):195–203. doi: 10.1128/jb.69.2.195-203.1955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. ROTHBARD S. Protective effect of hyaluronidase and type-specific anti-M serum on experimental group A streptococcus infection in mice. J Exp Med. 1948 Sep 1;88(3):325–342. doi: 10.1084/jem.88.3.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. ROTHBARD S., WATSON R. F. Variation occurring in group A streptococci during human infection; progressive loss of M substance correlated with increasing susceptibility to bacteriostasis. J Exp Med. 1948 Jun 1;87(6):521–533. doi: 10.1084/jem.87.6.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. SALTON M. R. J. The nature of the cell walls of some gram-positive and gram-negative bacteria. Biochim Biophys Acta. 1952 Sep;9(3):334–335. doi: 10.1016/0006-3002(52)90172-8. [DOI] [PubMed] [Google Scholar]
  12. SMITH M. R., WOOD W. B., Jr An experimental analysis of the curative action of penicillin in acute bacterial infections. II. The role of phagocytic cells in the process of recovery. J Exp Med. 1956 Apr 1;103(4):499–508. doi: 10.1084/jem.103.4.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Smith M. R., Wood W. B. STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMONIA DUE TO FRIEDLADER'S BACILLUS : III. THE ROLE OF "SURFACE PHAGOCYTOSIS" IN THE DESTRUCTION OF THE MICROORGANISMS IN THE LUNG. J Exp Med. 1947 Aug 31;86(3):257–266. doi: 10.1084/jem.86.3.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Swift H. F., Wilson A. T., Lancefield R. C. TYPING GROUP A HEMOLYTIC STREPTOCOCCI BY M PRECIPITIN REACTIONS IN CAPILLARY PIPETTES. J Exp Med. 1943 Aug 1;78(2):127–133. doi: 10.1084/jem.78.2.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. TOMCSIK J. Complex structures of the bacterial capsule in the genus bacillus. Experientia. 1951 Dec;7(12):459–460. doi: 10.1007/BF02168692. [DOI] [PubMed] [Google Scholar]
  16. Todd E. W., Lancefield R. C. VARIANTS OF HEMOLYTIC STREPTOCOCCI; THEIR RELATION TO TYPE-SPECIFIC SUBSTANCE, VIRULENCE, AND TOXIN. J Exp Med. 1928 Nov 30;48(6):751–767. doi: 10.1084/jem.48.6.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. WILEY G. G., WILSON A. T. The ability of group A streptococci killed by heat or mercury arc irradiation to resist ingestion by phagocytes. J Exp Med. 1956 Jan 1;103(1):15–36. doi: 10.1084/jem.103.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. WOOD W. B., Jr, SMITH M. R. The inhibition of surface phagocytosis by the capsular slime layer of pneumococcus type III. J Exp Med. 1949 Jul;90(1):85–96. doi: 10.1084/jem.90.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. WOOD W. B., SMITH M. R. Host-parasite relationships in experimental pneumonia due to pneumococcus type III. J Exp Med. 1950 Jul 1;92(1):85–100. doi: 10.1084/jem.92.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ward H. K., Lyons C. STUDIES ON THE HEMOLYTIC STREPTOCOCCUS OF HUMAN ORIGIN : I. OBSERVATIONS ON THE VIRULENT, ATTENUATED, AND AVIRULENT VARIANTS. J Exp Med. 1935 Mar 31;61(4):515–530. doi: 10.1084/jem.61.4.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wood W. B., Smith M. R., Watson B. STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : IV. THE MECHANISM OF PHAGOCYTOSIS IN THE ABSENCE OF ANTIBODY. J Exp Med. 1946 Sep 30;84(4):387–402. doi: 10.1084/jem.84.4.387. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES